Delivery of adjuvant chemotherapy (AC) to veterans with resected colon cancer
Date
2012-06
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
ASCO Annual Meeting
Abstract
Patients with incomplete administration of AC for colon cancer (CC) likely experience inferior survival while oxaliplatin- and capecitabine-containing AC may not improve survival for older patients. The influence on AC completion of age, other baseline patient characteristics, or regimen characteristics is unknown. We evaluated the association of baseline characteristics and planned AC regimen with AC delivery in resected CC patients.
Description
Keywords
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Riggs, H., Lane, K., Loehrer, P., Hui, S., Rawl, S., Ormerod, A., Weiner, M. (2012). Delivery of adjuvant chemotherapy to veterans with resected colon cancer. [Abstract published in the Proceedings of the 2012 ASCO Annual Meeting, June, 2012.] J Clin Oncol 30, 2012. (Suppl; abstr e16557).
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Rights
Source
Alternative Title
Type
Other